Altering chromatin methylation patterns and the transcriptional network involved in regulation of hematopoietic stem cell fate
- PMID: 32052445
- DOI: 10.1002/jcp.29642
Altering chromatin methylation patterns and the transcriptional network involved in regulation of hematopoietic stem cell fate
Abstract
Hematopoietic stem cells (HSCs) are quiescent cells with self-renewal capacity and potential multilineage development. Various molecular regulatory mechanisms such as epigenetic modifications and transcription factor (TF) networks play crucial roles in establishing a balance between self-renewal and differentiation of HSCs. Histone/DNA methylations are important epigenetic modifications involved in transcriptional regulation of specific lineage HSCs via controlling chromatin structure and accessibility of DNA. Also, TFs contribute to either facilitation or inhibition of gene expression through binding to enhancer or promoter regions of DNA. As a result, epigenetic factors and TFs regulate the activation or repression of HSCs genes, playing a central role in normal hematopoiesis. Given the importance of histone/DNA methylation and TFs in gene expression regulation, their aberrations, including changes in HSCs-related methylation of histone/DNA and TFs (e.g., CCAAT-enhancer-binding protein α, phosphatase and tensin homolog deleted on the chromosome 10, Runt-related transcription factor 1, signal transducers and activators of transcription, and RAS family proteins) could disrupt HSCs fate. Herewith, we summarize how dysregulations in the expression of genes related to self-renewal, proliferation, and differentiation of HSCs caused by changes in epigenetic modifications and transcriptional networks lead to clonal expansion and leukemic transformation.
Keywords: epigenetic modifications; gene expression; hematopoietic stem cells; leukemia; transcriptional regulation.
© 2020 Wiley Periodicals, Inc.
Similar articles
-
Dynamics of Chromatin Accessibility During Hematopoietic Stem Cell Differentiation Into Progressively Lineage-Committed Progeny.Stem Cells. 2023 May 15;41(5):520-539. doi: 10.1093/stmcls/sxad022. Stem Cells. 2023. PMID: 36945732 Free PMC article.
-
Transcriptional and epigenetic control of hematopoietic stem cell fate decisions in vertebrates.Dev Biol. 2021 Jul;475:156-164. doi: 10.1016/j.ydbio.2021.03.003. Epub 2021 Mar 6. Dev Biol. 2021. PMID: 33689804 Review.
-
Hematopoietic stem cell development: an epigenetic journey.Curr Top Dev Biol. 2014;107:39-75. doi: 10.1016/B978-0-12-416022-4.00002-0. Curr Top Dev Biol. 2014. PMID: 24439802 Review.
-
Formation of an active tissue-specific chromatin domain initiated by epigenetic marking at the embryonic stem cell stage.Mol Cell Biol. 2005 Mar;25(5):1804-20. doi: 10.1128/MCB.25.5.1804-1820.2005. Mol Cell Biol. 2005. PMID: 15713636 Free PMC article.
-
Epigenetic plasticity of chromatin in embryonic and hematopoietic stem/progenitor cells: therapeutic potential of cell reprogramming.Leukemia. 2008 Aug;22(8):1503-18. doi: 10.1038/leu.2008.141. Epub 2008 Jun 12. Leukemia. 2008. PMID: 18548105 Review.
Cited by
-
Antileukemic Activity and Molecular Docking Study of a Polyphenolic Extract from Coriander Seeds.Pharmaceuticals (Basel). 2021 Aug 5;14(8):770. doi: 10.3390/ph14080770. Pharmaceuticals (Basel). 2021. PMID: 34451867 Free PMC article.
-
Regulation of adult stem cell quiescence and its functions in the maintenance of tissue integrity.Nat Rev Mol Cell Biol. 2023 May;24(5):334-354. doi: 10.1038/s41580-022-00568-6. Epub 2023 Mar 15. Nat Rev Mol Cell Biol. 2023. PMID: 36922629 Free PMC article. Review.
-
Identification of High-Frequency Methylation Sites in RNF180 Promoter Region Affecting Expression and Their Relationship with Prognosis of Gastric Cancer.Cancer Manag Res. 2020 May 13;12:3389-3399. doi: 10.2147/CMAR.S246995. eCollection 2020. Cancer Manag Res. 2020. PMID: 32494203 Free PMC article.
References
REFERENCES
-
- Abdel-Wahab, O., Adli, M., LaFave, L. M., Gao, J., Hricik, T., Shih, A. H., … Levine, R. L. (2012). ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression. Cancer Cell, 22(2), 180-193. https://doi.org/10.1016/j.ccr.2012.06.032
-
- Abdel-Wahab, O., Gao, J., Adli, M., Dey, A., Trimarchi, T., Chung, Y. R., … Levine, R. L. (2013). Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo. Journal of Experimental Medicine, 210(12), 2641-2659. https://doi.org/10.1084/jem.20131141
-
- An, J., Gonzalez-Avalos, E., Chawla, A., Jeong, M., Lopez-Moyado, I. F., Li, W., … Rao, A. (2015). Acute loss of TET function results in aggressive myeloid cancer in mice. Nature Communications, 6, 10071. https://doi.org/10.1038/ncomms10071
-
- Artinger, E. L., Mishra, B. P., Zaffuto, K. M., Li, B. E., Chung, E. K., Moore, A. W., … Ernst, P. (2013). An MLL-dependent network sustains hematopoiesis. Proceedings of the National Academy of Sciences of the United States of America, 110(29), 12000-12005. https://doi.org/10.1073/pnas.1301278110
-
- Asada, S., Fujino, T., Goyama, S., & Kitamura, T. (2019). The role of ASXL1 in hematopoiesis and myeloid malignancies. Cellular and Molecular Life Sciences, 76(13), 2511-2523. https://doi.org/10.1007/s00018-019-03084-7
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous